{"id":"W3170157402","doi":"10.1016/j.ctarc.2021.100421","title":"A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC)","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Centre Hospitalier de l’Université de Montréal","funders":"Merck","keywords":"Stage (stratigraphy); Pembrolizumab; Medicine; Oncology; Internal medicine; Paclitaxel; Nab-paclitaxel; Carcinoma; Chemotherapy; Cancer; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003455606,0.0001672481,0.000356165,0.0003149333,0.0002980921,0.00003322339,0.0002130124,0.0000561911,0.00009758812],"category_scores_gemma":[0.00001674401,0.0001106074,0.00002875079,0.001149726,0.0002232291,0.0001147278,0.0001733967,0.0002828112,2.724889e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008333504,"about_ca_system_score_gemma":0.001175944,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01379276,"about_ca_topic_score_gemma":0.04370185,"domain_scores_codex":[0.9983419,0.0003413373,0.0003115644,0.0003050954,0.0003796833,0.0003204291],"domain_scores_gemma":[0.9981173,0.0001924876,0.00009527556,0.001045343,0.0004544251,0.00009511986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03194141,0.04516632,0.8955336,0.0002634508,0.0003815512,0.00006531223,0.01585052,0.00001434101,0.001590839,0.0000292795,0.00008349022,0.009079833],"study_design_scores_gemma":[0.2749485,0.04547032,0.6475347,0.0008681843,0.0001680648,0.000002765668,0.02514238,0.001096954,0.002795502,0.000003516802,0.001693928,0.0002751477],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908946,0.005110889,0.000003402349,0.0005165147,0.00001337156,0.002482564,0.00007183624,0.000009118071,0.0008976915],"genre_scores_gemma":[0.9906484,0.003532064,0.0001148834,0.00001702342,0.000005882765,0.00087923,0.0001673746,0.00002333604,0.004611809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2479989,"threshold_uncertainty_score":0.9927745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07057552295191545,"score_gpt":0.3883166627883285,"score_spread":0.3177411398364131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}